Top Stories

Dapagliflozin approved in Europe for CKD, regardless of diabetes status

Dapagliflozin (Forxiga) has been approved in the European Union for the treatment of chronic kidney disease (CKD) in adults with and without type-2 …

Read more @ www.urologytimes.com

Back to top button